Celiac disease-associated antibodies in patients with psoriasis and correlation with HLA Cw6

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 4, 2010, Pages 269-272

  Singh, Sangeeta ^a   Sonkar, Gyanendra Kumar ^b   Usha, ^a   Singh, Sanjay ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Anti gliadin IgA; Anti gliadin IgG; Anti tissue transglutaminase IgA; Celiac disease; Psoriasis

Indexed keywords

GLIADIN ANTIBODY; GLUTEN; HLA C ANTIGEN; HLA CW 6 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROTEIN EXPRESSION; PSORIASIS; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; GLIADIN; HLA-C ANTIGENS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PSORIASIS; TRANSGLUTAMINASES;

EID: 77955639697     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20398     Document Type: Article

References (28)

1. Wolters M. Diet and psoriasis: Experimental data and clinical evidence. Br J Dermatol 2005;153:706-714. (Pubitemid 41415895)
2. Bianchi L, Farrace MG, Nini G, Piacentini M. Abnormal Bcl-2 and "tissue" transglutaminase expression in psoriasis skin. J Invest Dermatol 1994;103:829-833.
3. Michaelsson G, Gerden B, Hagforsen E, et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol 2000;142:44-51. (Pubitemid 30074469)
4. Lindqvist U, Rudsander A, Bostrom A, Nilsson B, Michaelsson G. IgA antibodies to gliadin and CD in psoriatic arthritis. Rheumatology 2002;4:31-37. (Pubitemid 34537918)
5. Woo WK, McMillan SA, Watson RGP, et al. CD-associated antibodies correlate with psoriasis activity. Br J Dermatol 2004;15:891-894.
6. Kia KF, Nair RP, Ike RW, Hiremagalore R, Elder JT, Ellis CN. Prevalence of antigliadin antibodies in patients with psoriasis is not elevated compared with controls. Am J Clin Dermatol 2007;8:301-305. (Pubitemid 47533556)
7. Marks J, Shuster S. Psoriatic enteropathy. Arch Dermatol 1971;103:676-678.
8. Michaelsson G, Ash S, Hammarstrom I, Lundin IP, Hagforsen E. Gluten-free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67z cells in the dermis. Acta Derm Venereol 2003;83:425-429. (Pubitemid 37475782)
9. Corazza GR, Gasbarrini G. Coeliac disease in adults. Baillieres Clin Gastroenterol 1995;9:329-350.
10. Dieterich W, Esslinger B, Trapp D, et al. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut 2006;55:478-484.
11. Nickoloff BJ. The immunologic amd genetic basis of psoriasis. Arch Dermatol 1999;135:1104-1110.
12. Veal CD, Capon F, Allen MH, et al. Family based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. Am J Hum Genet 2002;71:554-564. (Pubitemid 34970126)
13. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204:998-1000.
14. Mehra NK. Basic methods in HLA-DNA technology. Technical Manual Published During the DBT Sponsored Training Workshop on HLA-DNA Technology. New Delhi: Sagar Publishers, 1989.
15. Connon JJ. CD. In: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern Nutrition in Health and Disease, 9th edn. Baltimore: Williams & Wilkins. 1999. p 1163-1168.
16. Baum C, Moxon D, Scott M. Gastrointestinal disease. In: Bowman BA, Russell RM, editors. Present Knowledge in Nutrition. Washington, DC: ILSI Press. 2001. p 472-482.
17. Addolorato G, Parente A, de Lorenzi G, et al. Rapid regression of psoriasis in a coeliac patient after gluten free diet. Digestion 2003;68:9-12.
18. Michaelsson G, Kraaz W, GerdeÂn B, et al. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol 1993;129:66-73.
19. Cardinali C, Degl'innocenti D, CaproniM, Fabbri P. Is the search for serum antibodies to gliadin, endomysium and tissue transglutaminase meaningful in psoriatic patients? Relationship between thepathogenesis of psoriasis and CD. Br J Dermatol 2002;147:187-188. (Pubitemid 34779465)
20. Damasiewicz-Bodzek A, Wielkoszyński T. Serologic markers of CD in psoriatic patients. J Euro Acad Dermatol Venereol 2008;22:1055-1061.
21. Winklhofer-Roob BM, Rossipal E, Lanzer G. Human leucocyte class I and II antigens in coeliac disease:a study in an Austrian paediatric population. Eur J Pediatr 1991;150:704-707.
22. DeMarchi M, Carbonara A, Ansaldi N, et al. HLA-DR3 and DR7 in coeliac disease: immunogenetic and clinical aspects. Gut 1983;24:706-712. (Pubitemid 13030235)
23. Brautbar C, Freier S, Ashkenazi A, et al. Histocompatibility determinants in Israeli Jewish patients with coeliac disease: Population and family study. Tissue Antigens 1981;17:313-322. (Pubitemid 11157100)
24. Schon MP, Boehnecke H. Psoriasis. N Engl J Med 2005;352:1899-1912.
25. Schuppan D. Current concepts of CD pathogenesis. Gastroenterology 2000;119:234-242.
26. Fogh K, Kragballe K. New vitamin D analogs in psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:199-204.
27. Holick MF. Vitamin D: A millennium perspective. J Cell Biochem 2003;88:296-307.
28. Capristo E, Addolorato G, Mingrone G, et al. Changes in body composition, substrate oxidation, and resting metabolic rate in adult celiac disease patients after a 1-y gluten-free diet treatment. Am J Clin Nutr 2000;72:76-81. (Pubitemid 30441660)